Amiloxate

Amiloxate

SCHEMBL128151

CCCCCC(CC)OC(=O)C=Cc1ccc(OC)cc1.COc1ccc(C=CC(=O)OCCC(C)C)cc1

nearest known ligand 0.71

Full drug profile on Sugi Atlas →

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.71
LMNA P02545 2/20 0.71
SMN1; SMN2 Q16637 1/20 0.50
TAS1R3 Q7RTX0 5/20 0.47
TAS1R1 Q7RTX1 5/20 0.47
APP P05067 5/20 0.45
THRB P10828 1/20 0.42
ATM Q13315 1/20 0.42
GSK3B P49841 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7606022 0.92 TDP1 (0.60) TDP1LMNASMN1; SMN2TAS1R3TAS1R1
Amiloxate SCHEMBL128150 0.91 TDP1 (0.59) TDP1LMNASMN1; SMN2TAS1R3TAS1R1
SCHEMBL35995 0.90 TDP1 (0.62) TDP1LMNASMN1; SMN2TAS1R3TAS1R1
SCHEMBL35994 0.90 TDP1 (0.62) TDP1LMNASMN1; SMN2TAS1R3TAS1R1
SCHEMBL14698300 0.90 TDP1 (0.62) TDP1LMNASMN1; SMN2TAS1R3TAS1R1
SCHEMBL28036638 0.89 TDP1 (0.61) TDP1LMNASMN1; SMN2TAS1R3TAS1R1
SCHEMBL28200368 0.88 TDP1 (0.60) TDP1LMNASMN1; SMN2TAS1R3TAS1R1
SCHEMBL28313815 0.87 TDP1 (0.58) TDP1LMNASMN1; SMN2TAS1R3TAS1R1
4-Methoxycinnamic Acid SCHEMBL19717781 0.87 TDP1 (0.58) TDP1LMNASMN1; SMN2TAS1R3TAS1R1
Amiloxate SCHEMBL128152 0.86 LMNA (0.57) TDP1LMNASMN1; SMN2TAS1R3TAS1R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1965758-B1 COMPOSITIONS CONTAINING PROTEINS FOR THE TRANSFER/RECYCLING OF STRUCTURALLY MODIFIED LIPIDS, AND THE APPLICATIONS THEREOF MERZ PHARMA GMBH & CO KGAA (DE) 2012-03-07 EP disclosed